Alkemy Capital Investments PLC
11 August 2026
11 August 2026
Alkemy Capital Investments Plc
Loan Conversion
Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £106,416.66 of principal and £17,313.97 of interest is being converted at £2.38, resulting in the issue of 51,887 ordinary shares of 2 pence each in the Company ("Ordinary Shares").
The Company will accordingly issue 51,887 new Ordinary Shares in the Company (the "New Ordinary Shares").
Admission
Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 14 August 2026 ("Admission").
Total Voting Rights
The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 11,186,967 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Further information
For further information, please visit Alkemy's website:www.alkemycapital.co.ukor TVL's websitewww.teesvalleylithium.co.uk.
-Ends-
|
Alkemy Capital Investments Plc |
Tel: 0207 317 0636 |
|
Zeus Capital |
Tel: 0203 829 5000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.